uterine atony.
Conditions
Interventions
Intervention 1: Intervention group: carbetocin. Intervention 2: Intervention group: Oxytocin.
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
No minimum to 45 Years
Inclusion criteria
Inclusion criteria: Pregnant women referred to Bharlo Hospital with a gestational age of over 37 weeks who are candidates for elective cesarean section
Exclusion criteria
Exclusion criteria: Pregnant mothers over 45 years old Gestational age below 37 weeks Pregnant women who are candidates for emergency caesarean section Pregnant women with chronic blood pressure diseases Duration of surgery more than one hour Pregnant mothers with a history of fibroma and bleeding in a previous delivery Pregnant mothers with a history of placenta previa and placental accreta • Mothers with twins
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin levels of people in the intervention process. Timepoint: Before cesarean section, after cesarean section, and in the recovery room after receiving blood or serum if needed. Method of measurement: laboratory.;Body Mass Index. Timepoint: When entering the study. Method of measurement: From dividing weight (kilograms) by height (meters) to the power of 2.;Gravid. Timepoint: When entering the study. Method of measurement: Case information and questions from the mother.;Mother's age. Timepoint: When entering the study. Method of measurement: Case information and questions from the mother.;Systolic blood pressure. Timepoint: Before cesarean section, after cesarean section, and in the recovery room after receiving blood or serum if needed. Method of measurement: Blood pressure monitor.;?Diastolic Blood pressure. Timepoint: Before cesarean section, after cesarean section, and in the recovery room after receiving blood or serum if needed. Method of measurement: Blood pressure monitor.;Heart rate. Timepoint: Before cesarean section, after cesarean section, and in the recovery room after receiving blood or serum if needed. Method of measurement: monitoring.;Nausea and vomiting. Timepoint: Before cesarean section, after cesarean section, and in the recovery room after receiving blood or serum if needed. Method of measurement: Monitoring. | — |
Secondary
| Measure | Time frame |
|---|---|
| Carbetocin. Timepoint: after cesarean section. Method of measurement: In intervention group 2, 100 micrograms of carbetocin diluted in 5 cc of distilled water was injected slowly over one minute.;Oxytocin. Timepoint: after cesarean section. Method of measurement: 20 units of oxytocin injected immediately after placental delivery.;. Timepoint: . Method of measurement: .;Oxytocin. Timepoint: after cesarean section. Method of measurement: 20 units of oxytocin injected immediately after placental delivery.;Need for blood transfusion. Timepoint: If needed and hemoglobin drops. Method of measurement: Laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Ali Ahmadi
Tehran University of Medical Sciences
Outcome results
None listed